Norepinephrine (NE) is synthesized in the locus coeruleus
and widely
projected throughout the brain and spinal cord. It regulates various
actions and consciousness linked to a variety of neurological diseases.
A “hunting–shooting” strategy was proposed in
this work to improve the specificity and response rate of an NE fluorescent
probe: 2-(cyclohex-2-en-1-ylidene)malononitrile derivatives were chosen
as a fluorophore. To create a dual-site probe, an aldehyde group was
added to the ortho of the ester group (or benzene
sulfonate). Because of its excellent electrophilic activity, the aldehyde
group could rapidly “hunt” the amino group and then
form an intramolecular five-membered ring via the
nucleophilic reaction with the β-hydroxyl group. The −NH–
in the five-membered ring “shoots” the adjacent ester
group, releasing the fluorophore and allowing for rapid and specific
NE detection. The NE release and reuptake ″emetic″–″swallow″
transient process is captured and visualized under the action of the
primary NE receptor drug. Furthermore, by introducing halogen into
the fluorophore to lengthen the absorption wavelength, improve lipid
solubility, and adjust the pK
a appropriately,
the probe successfully penetrated the blood–brain barrier (BBB). In situ synchronous probe imaging was used to detect the
NE level in the brains of epileptic and normal mice, and abnormal
expression of NE in the brain was discovered during epilepsy. Brain
anatomy was used to examine the distribution and level changes of
NE in various brain regions before and after epilepsy. This research
provides useful tools and a theoretical foundation for diagnosing
and treating central nervous system diseases early.